TG Therapeutics Inc (TGTX.OQ)
TGTX.OQ on NASDAQ Stock Exchange Capital Market
7.00USD
21 May 2019
7.00USD
21 May 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$7.00
$7.00
Open
$6.79
$6.79
Day's High
$7.00
$7.00
Day's Low
$6.76
$6.76
Volume
378,223
378,223
Avg. Vol
539,768
539,768
52-wk High
$15.95
$15.95
52-wk Low
$3.41
$3.41
About
TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)
Overall
| Beta: | 1.34 |
| Market Cap(Mil.): | $846.68 |
| Shares Outstanding(Mil.): | 68.84 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| TGTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.30 | 32.55 |
| EPS (TTM): | -1.95 | -- | -- |
| ROI: | -129.83 | 8.91 | 13.82 |
| ROE: | -133.51 | 10.05 | 15.24 |
Estimates